Others found increased CD8+ and decreased CD4+ T cells in BOS patients versus controls, with increased CD8+ T cells in BOS versus stable LTR [45, 46, 54] and controls [54]. This evidence concerns the gene CD8A and Buschke-Ollendorff syndrome.